Protocatechuic acid inhibits proliferation, migration and inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes

References

• Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356–361.
   PubMed Web of Science ®Google Scholar
• Beatrix B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233(1):233–255.
   PubMedGoogle Scholar
• Charles J, Britt H, Pan Y. Rheumatoid arthritis. Aust Fam Physician. 2013;42(11):765.
   PubMedGoogle Scholar
• Nunzio B, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013;9(1):24–33.
   PubMed Web of Science ®Google Scholar
• Asif Amin M, Fox DA, Ruth JH. Synovial cellular and molecular markers in rheumatoid arthritis. Semin Immunopathol. 2017;39(4):385–393.
   PubMed Web of Science ®Google Scholar
• Drevensek G, Lunder M, Benkovic ET, et al. Cardioprotective effects of silver fir (Abies alba) extract in ischemic-reperfused isolated rat hearts. Food Nutr Res. 2016;60:29623.
   PubMed Web of Science ®Google Scholar
• Harini R, Pugalendi KV. Antihyperglycemic effect of protocatechuic acid on streptozotocin-diabetic rats. J Basic Clin Physiol Pharmacol. 2011;21:79–92.
   Google Scholar
• Tanaka T, Kojima T, Suzui M, et al. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis. Cancer Res. 1993;53(17):3908–3913.
   PubMed Web of Science ®Google Scholar
• Son JH, Kim SY, Jang HH, et al. Protective effect of protocatechuic acid against inflammatory stress induced in human dermal fibroblasts. Biomed Dermatol. 2018;2(1):9.
   Google Scholar
• Wongwichai T, Teeyakasem P, Pruksakorn D, et al. Anthocyanins and metabolites from purple rice inhibit IL-1β-induced matrix metalloproteinases expression in human articular chondrocytes through the NF-κB and ERK/MAPK pathway. Biomed Pharmacother. 2019;112:108610.
   PubMed Web of Science ®Google Scholar
• Huh JE, Hong JM, Baek YH, et al. Anti-inflammatory and anti-nociceptive effect of Betula platyphylla var. japonica in human interleukin-1β-stimulated fibroblast-like synoviocytes and in experimental animal models. J Ethnopharmacol. 2011;135(1):126–134.
   PubMed Web of Science ®Google Scholar
• Pap T, Müller-Ladner U, Gay RE, et al. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2000;2(5):361–367.
   PubMedGoogle Scholar
• Lipsky PE, Davis LS, Cush JJ, et al. The role of cytokines in the pathogenesis of rheumatoid arthritis. Springer Semin Immunopathol. 1989;11(2):123–162.
   PubMed Web of Science ®Google Scholar
• Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum. 1996;39(11):1781–1790.
   PubMedGoogle Scholar
• Zhu Q, Huang J, Wang SZ, et al. Cobrotoxin extracted from Naja atra venom relieves arthritis symptoms through anti-inflammation and immunosuppression effects in rat arthritis model. J Ethnopharmacol. 2016;194:1087–1095.
   PubMed Web of Science ®Google Scholar
• Gilmore T. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006;25(51):6680–6684.
   PubMed Web of Science ®Google Scholar
• Baeuerle PA. IkappaB-NF-kappaB structures: at the interface of inflammation control. Cell. 1998;95(6):729–731.
   PubMed Web of Science ®Google Scholar
• Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107(1):7–11.
   PubMed Web of Science ®Google Scholar
• Makarov SS. NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Res. 2001;3(4):200–206.
   PubMedGoogle Scholar
• Hartkamp LM, Grabiec AM, Ludikhuize J, et al. Functional interactions between PI3-kinase and NF-κB signaling pathways promote joint destruction in rheumatoid arthritis. Ann Rheum Dis. 2011;70(2):A27–A28.
   Google Scholar
• Sarmiento Salinas FL, Santillán Benítez JG, Hernández Navarro MD, et al. NF-κB1/IKKε gene expression and clinical activity in patients with rheumatoid arthritis. Lab Med. 2017;49(1):11–17.
   PubMed Web of Science ®Google Scholar
• Roman-Blas JA, Jimenez SA. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthr Cartil. 2006;14(9):839–848.
   PubMed Web of Science ®Google Scholar
• Loo GV, Beyaert R. Negative regulation of NF-κB and its involvement in rheumatoid arthritis. Arthritis Res Ther. 2011;13(3):221–231.
   PubMed Web of Science ®Google Scholar
• Okamoto H, Yoshio T, Kaneko H, et al. Inhibition of NF-kappaB signaling by fasudil as a potential therapeutic strategy for rheumatoid arthritis. Arthritis Rheum. 2010;62(1):82–92.
   PubMedGoogle Scholar
• Wang J, Zhao Q. Kaempferitrin inhibits proliferation, induces apoptosis, and ameliorates inflammation in human rheumatoid arthritis fibroblast-like synoviocytes. Phytother Res. 2019;33(6):1726–1735.
   PubMed Web of Science ®Google Scholar
• Chen K, Lin ZW, He SM, et al. Metformin inhibits the proliferation of rheumatoid arthritis fibroblast-like synoviocytes through IGF-IR/PI3K/AKT/m-TOR pathway. Biomed Pharmacother. 2019;115:108875–108882.
   PubMed Web of Science ®Google Scholar
• Laragione T, Gulko PS. mTOR regulates the invasive properties of synovial fibroblasts in rheumatoid arthritis. Mol Med. 2010;16(9–10):352–358.
   PubMed Web of Science ®Google Scholar
• Nam YJ, Lee CS. Protocatechuic acid inhibits Toll-like receptor-4-dependent activation of NF-κB by suppressing activation of the Akt, mTOR, JNK and p38-MAPK. Int Immunopharmacol. 2018;55:272–281.
   PubMed Web of Science ®Google Scholar